Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 28 June 2018

Indication(s)

INVEGA is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older.

INVEGA is indicated for the treatment of schizoaffective disorder in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Atopic Dermatitis

Atopic Dermatitis

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/000746
Orphan designation No
Date First Approved 25-06-2007
Type Medicinal product subject to medical prescription
Marketing authorisation holder Janssen-Cilag International NV